Deposition of complement C 9 in primary sclerosing cholangitis.

被引：0
|
作者：
Shanahan, J
Rosenberg, W
Chapman, R
Fleming, K
机构：
[1] Nuffield Dept Pathol & Bacteriol, Southampton, Hants, England
[2] Univ Southampton, Dept Med, Southampton, Hants, England
[3] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England
来源：
JOURNAL OF PATHOLOGY | 1998年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：32A / 32A
页数：1
相关论文
共 50 条
  • [21] Prevalence and progression of bone disease in primary sclerosing cholangitis.
    Angulo, P
    Therneau, T
    Jorgensen, R
    Dickson, ER
    Lindor, KD
    GASTROENTEROLOGY, 1997, 112 (04) : A1213 - A1213
  • [22] Characterization of histone autoantibodies in patients with primary sclerosing cholangitis.
    Orth, T
    zumBuschenfelde, KHM
    Mayet, WJ
    HEPATOLOGY, 1997, 26 (04) : 1255 - 1255
  • [23] ERCP associated complications in patients with primary sclerosing cholangitis.
    Eng, SC
    Lee, SD
    Kimmey, MB
    Tung, BY
    Saunders, MD
    Kowdley, KV
    HEPATOLOGY, 2001, 34 (04) : 524A - 524A
  • [24] Prediction of esophageal varices in patients with primary sclerosing cholangitis.
    Angulo, P
    Therneau, T
    Larson, D
    Dickson, ER
    Lindor, KD
    HEPATOLOGY, 1997, 26 (04) : 1382 - 1382
  • [25] HLA polymorphism in German patients with primary sclerosing cholangitis.
    Chen, DF
    Tillmann, HL
    Pastucha, L
    Luttig, B
    RobinWinn, M
    Endres, W
    Manns, MP
    Stangel, W
    HEPATOLOGY, 1996, 24 (04) : 173 - 173
  • [26] The profile and significance of serum autoantibodies in primary sclerosing cholangitis.
    Angulo, P
    DeSotel, CK
    Gershwin, ME
    Shoenfeld, Y
    Ahmed, A
    Peter, J
    Lindor, KD
    HEPATOLOGY, 1998, 28 (04) : 444A - 444A
  • [27] The time course of histological progression in primary sclerosing cholangitis.
    Angulo, P
    Therneau, TM
    Larson, DR
    Batts, KP
    LaRusso, NF
    Lindor, KD
    GASTROENTEROLOGY, 1998, 114 (04) : A1204 - A1204
  • [28] Activin A is selectively upregulated in advanced primary sclerosing cholangitis.
    Schramm, C
    Stuermer, C
    Lohse, AW
    Galle, PR
    Blessing, M
    HEPATOLOGY, 2004, 40 (04) : 465A - 465A
  • [29] S-CA19-9 and S-CEA in primary sclerosing cholangitis.
    Farkkila, MA
    Karvonen, AL
    Pikkarainen, P
    Nurmi, H
    Nuutinen, H
    Miettinen, TA
    GASTROENTEROLOGY, 1996, 110 (04) : A1188 - A1188
  • [30] A pilot study evaluating pentoxifylline in the treatment of primary sclerosing cholangitis.
    Bharucha, AE
    Jorgensen, RA
    Lichtman, SN
    Gores, GJ
    LaRusso, NF
    Plevy, SA
    Lindor, KD
    HEPATOLOGY, 1997, 26 (04) : 1096 - 1096
12345